Satué Katy, Miguel-Pastor Laura, Chicharro Deborah, Gardón Juan Carlos
Department of Animal Medicine and Surgery, Faculty of Veterinary, CEU-Cardenal Herrera University, 46115 Valencia, Spain.
Department of Animal Medicine and Surgery, Faculty of Veterinary and Experimental Science, Catholic University of Valencia-San Vicente Mártir, 46001 Valencia, Spain.
Animals (Basel). 2022 Mar 29;12(7):861. doi: 10.3390/ani12070861.
For diagnostic purposes, liver enzymes are usually classified into hepatocellular and cholestatic. These two groups of equine liver-specific enzymes include sorbitol dehydrogenase (SDH), glutamate dehydrogenase (GLDH), γ-glutamyl transferase (GGT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and alkaline phosphatase (ALP). SDH and GLDH mostly reflect hepatocellular injury and cholestasis, while GGT expresses high values in biliary necrosis or hyperplasia. Likewise, AST, LDH, and ALP also reflect hepatocellular and biliary disease, but these enzymes are not liver specific. From the clinical point of view of the course of liver or biliary disease, AST and ALP are indicative of chronic disease, whereas SDH, GGT, and GLDH indicate an acute course. The patterns of enzymatic changes at the blood level are associated with different types of liver pathologies (infectious, inflammatory, metabolic, toxic, etc.). Increases in hepatocellular versus biliary enzyme activities are indicative of a particular process. There are different ways to diagnose alterations at the hepatic level. These include the evaluation of abnormalities in the predominant pattern of hepatocellular versus cholestatic enzyme abnormalities, the mild, moderate, or marked (5−10-fold or >10-fold) increase in enzyme abnormality concerning the upper limit of the reference range, the evolution over time (increase or decrease) and the course of the abnormality (acute or chronic).
出于诊断目的,肝脏酶通常分为肝细胞性和胆汁淤积性两类。这两组马肝脏特异性酶包括山梨醇脱氢酶(SDH)、谷氨酸脱氢酶(GLDH)、γ-谷氨酰转移酶(GGT)、天冬氨酸氨基转移酶(AST)、乳酸脱氢酶(LDH)和碱性磷酸酶(ALP)。SDH和GLDH主要反映肝细胞损伤和胆汁淤积,而GGT在胆汁坏死或增生时表达值较高。同样,AST、LDH和ALP也反映肝细胞和胆管疾病,但这些酶并非肝脏特异性的。从肝脏或胆管疾病病程的临床角度来看,AST和ALP提示慢性疾病,而SDH、GGT和GLDH提示急性病程。血液中酶变化的模式与不同类型的肝脏病变(感染性、炎症性、代谢性、中毒性等)相关。肝细胞酶活性与胆管酶活性的增加提示特定的过程。有不同的方法来诊断肝脏水平的改变。这些方法包括评估肝细胞性酶异常与胆汁淤积性酶异常的主要模式中的异常情况、酶异常相对于参考范围上限的轻度、中度或显著(5至10倍或>10倍)增加、随时间的演变(增加或减少)以及异常的病程(急性或慢性)。